Tenderwize
Retour à la recherche

Medicinal product with active combination Formoterol, Glycopyrroniumbromide and Beclometason (ATC R03AL09)

AOK Sachsen - Anhalt·Magdeburg, Germany·Deadline Mar 30, 2028 · 580 days left·Open·Supplies
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Arzneimittel mit der Wirkstoffkombination Wirkstoffkombination Formoterol, Glycopyrroniumbromid und Beclometason (ATC-Code: R03AL09)

50/100

Score d'opportunité

Needs reviewLow complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

50 / 100

Complexité

20 / 100

Facteurs de risque

Contracts may be terminated early if AOK Sachsen-Anhalt decides to tender exclusive contracts for the same active ingre...

The notice explicitly states it is not a public procurement under GWB/EU directives, so legal remedies under procuremen...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration 2 YEAR
  • Non-exclusive discount agreements for finished medicinal products with active combination Formoterol, Glycopyrroniumbromide and Beclometason (ATC R03AL09)
  • Open-house model: any eligible pharmaceutical company can conclude a contract at any time under uniform conditions
Afficher le résumé complet

Non-exclusive discount agreement (open-house model) for pharmaceutical products with active combination Formoterol, Glycopyrroniumbromide and Beclometason (ATC R03AL09) by AOK Sachsen-Anhalt. The procedure is explicitly not a public procurement under GWB, published for transparency. Any eligible pharmaceutical company can join at any time under uniform conditions. Contract duration up to 24 months, earliest start 01.06.2026, end 31.05.2028. No estimated value or award criteria provided.

Risques

Contracts may be terminated early if AOK Sachsen-Anhalt decides to tender exclusive contracts for the same active ingre...

The notice explicitly states it is not a public procurement under GWB/EU directives, so legal remedies under procuremen...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Administrative

  • Interested pharmaceutical companies must request participation documents and the contract from the contact address
  • Participation requires fully completed and signed participation documents
  • Submission of documents via postal mail or electronically with qualified electronic signature (eIDAS) to [email protected]

Les exigences peuvent être incomplètes.

Acheteur

Localisation

Magdeburg, DEU

Profil acheteur

Ouvrir le profil

Identifiant

DE258393558

Activité

Health

Lots (1)

LOT-0001

Medicinal product with active combination Formoterol, Glycopyrroniumbromide and Beclometason (ATC R03AL09)

Non-exclusive discount agreement under §130a(8) SGB V for the specified active combination, open-house model with anytime accession. No exclusivity, no individual negotiations. Contract ends 31.05.2028 regardless of start date; may be terminated earlier if exclusive contracts are tendered.

SuppliesEU fundedElectronic submission

Localisation

DEE03, Germany

Durée

2 YEAR

Catégorie

Pharmaceutical products

Date limite

Deadline Mar 30, 2028

Détails de la procédure

Date de publication
20 Apr 2026
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
272002-2026

Documents (1)

Appels d'offres similaires